A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 587
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : RAI
Long Form : radioactive iodine
No. Year Title Co-occurring Abbreviation
2019 A 2017 SURVEY OF THE CLINICAL PRACTICE PATTERNS IN THE MANAGEMENT OF RELAPSING GRAVES DISEASE. ATD, GD
2019 A Case of Radioactive Iodine Uptake Found in Artificial Eye. ---
2019 An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy. DTC, Tg
2019 Assessment of Parotid and Submandibular Glands With Shear Wave Elastography Following Radioactive Iodine Therapy for Papillary Thyroid Carcinoma. PTC, SWVs
2019 Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy. DTC, RFS, THW, WBS
2019 Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer. ATA, DTC, IPTW
2019 Comparison of Mean Platelet Volume, Platelet Count, Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma. MPV, NLR, PLR, PTC, SCH, TSH
2019 Considerations for Thyroidectomy as Treatment for Graves Disease. ATDs, TSH
2019 Does the dose of iodine-131 influence the incidence of Graves' ophthalmopathy? GO
10  2019 Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway. PTC
11  2019 Factitious thyrotoxicosis: how to find it. Tg, TgAbs
12  2019 High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy? pCND, pN1a, PTC
13  2019 INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION. CI, CR, rhTSH, SEER
14  2019 Lingual ectopic papillary thyroid carcinoma: Two case reports and review of the literature. LTC
15  2019 Long-term monitoring of Graves’ disease in children and adolescents: a single-center experience ATD, GD
16  2019 Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience. ATD, CBZ, DT, DT, TPO
17  2019 MANAGEMENT OF THYROTOXICOSIS AMONG GENERAL PRACTITIONERS IN TRINIDAD COMPARED WITH 2016 AMERICAN THYROID ASSOCIATION GUIDELINES FOR HYPERTHYROIDISM. GPs
18  2019 Papillary thyroid carcinoma with bilateral axillary lymph node involvement: a case report outlining hypothesis for locoregional spread and therapeutic implications. ALNI, WDPTC
19  2019 Pattern of urine iodine excretion with low iodine diet during preparation for radioactive iodine ablation in patients with thyroid cancer. rhTSH, UIE
20  2019 Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs lobectomy. HRQoL, LA, TAs
21  2019 Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod). THW, ThyrNod
22  2019 Repeat Ultrasonography in the First Years after Therapy with Radioiodine Is Not Necessary in Most Patients with Papillary Thyroid Carcinoma when Postoperative Ultrasonography Is Negative: A Reduction of Costs and False-Positives. PTC, US
23  2019 Role of P53, E-cadherin and BRAF as predictors of regional nodal recurrence for papillary thyroid cancer. IHC, PTC, RNR
24  2019 Simultaneous Hodgkin lymphoma and BRAFV600E-positive papillary thyroid carcinoma: A case report. HL, PTC
25  2019 Stimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers. DTC, Pre-sTg, sTg, THW, TRI
26  2019 The BRAFV600E mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy? PTMC
27  2019 The Impact of Zoledronic Acid and Radioactive Iodine Therapy on Morbi-Mortality of Patients with Bone Metastases of Thyroid Cancer Derived from Follicular Cells. DTC, OS, SRE, ZA
28  2019 The Influence of Energy Depletion by Metformin or Hypocaloric Diet on Thyroid Iodine Uptake in Healthy Volunteers: a Randomized Trial. AMPK
29  2019 The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer CI, DM, LNM, Tg, TSH
30  2019 The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use? ROC, sTg
31  2019 Tumor doubling time predicts response to sorafenib in radioactive iodine-refractory differentiated thyroid cancer. AEs, DTC, HFSR, HR, PFS
32  2018 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Ab, ATD, GD, MMI, TSHR
33  2018 30mCi radioactive iodine achieving comparative excellent response in intermediate/high-risk nonmetastatic papillary thyroid cancer: a propensity score matching study. ER, PSM, PTC
34  2018 A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study. AMH, DTC
35  2018 A somatic mutation of RasGRP3 decreases Na+/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway. TSHR
36  2018 A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer. CI, df, SMNs, TC
37  2018 Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer: a clinical survey among endocrinologists and surgeons. ENT, FNA, PTC, stTg, Tg
38  2018 Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma. PTC
39  2018 Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer. HR, OS, PTC, TT
40  2018 Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer. PTC, Tg
41  2018 Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy. CI, CVDs, HR
42  2018 Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study. CLN, CSS, ELN, N0-e0, OS, PTC, TCV
43  2018 Changes in the size of the thyroid in patients with benign non-toxic multinodular goiter after radioactive iodine therapy. MNG
44  2018 Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey. DTC, Tg
45  2018 Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients. rhTSH, Tg, THW, TSH
46  2018 Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers. ATA, DTCs, TKIs
47  2018 CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma. EMT, FTC, rh-SDF1alpha
48  2018 Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015. CI, DTC, OR
49  2018 Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective. CI, DTC, OR, Tg, WBS
50  2018 Differentiated thyroid cancer and selenium supplements for protection of salivary glands from 131I treatment. DTC, Se, TPOAb, TSH
51  2018 Differentiated thyroid cancer theranostics: radioiodine and beyond. DTC, FDG, PET-CT, SPECT-CT, WBS
52  2018 Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer. ATC, DLCs, hNIS, LC3
53  2018 Effect of radioactive iodine-induced hypothyroidism on longitudinal bone growth during puberty in immature female rats. ---
54  2018 Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. CI, DFS, DMF, DTC, LRF, mETE
55  2018 Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection. p-CND, PTC
56  2018 Expression of ADAMTS2 and ADAMTS5 in the salivary gland of rats after radioiodine therapy. SG
57  2018 Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer. ATA
58  2018 How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules. EFVPTC, FT-UMP, NIFTP, PMC, UMP, WDT-UB, WDT-UMP
59  2018 Hyperthyroidism is Underdiagnosed and Undertreated in 3336 Patients: An Opportunity for Improvement and Intervention. TSH
60  2018 I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy. ---
61  2018 IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer. FTC, IAPs
62  2018 Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. cPTC, DTC, MTDs
63  2018 Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma. DTC
64  2018 Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer. ALB, ALP, AST, DBIL, DTC, GGT, GLO, TBIL, TP
65  2018 Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy. CI, OR
66  2018 Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma. ATA, MDTC
67  2018 Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence. PTC
68  2018 Neck Ultrasound in Patients with Follicular Thyroid Carcinoma. ATA, FTC, Tg, US
69  2018 Novel targeted therapies and immunotherapy for advanced thyroid cancers. DTC, MTC, TKR
70  2018 Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer. AEs, DTC, RAI-R DTC
71  2018 Papillary thyroid microcarcinoma: characteristics at presentation, and evaluation of clinical and histological features associated with a worse prognosis in a Latin American cohort. ---
72  2018 Pattern of presentation of Graves' disease and response to radioiodine therapy in South African men. ATD, GD, RAIT
73  2018 Prognosis of Differentiated Thyroid Carcinoma with Initial Distant Metastasis: A Multicenter Study in Korea. DSS, DTC
74  2018 Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up. CSS, DTC, PD, PFS
75  2018 Prognostic Value of Stimulated Thyroglobulin Levels at the Time of Radioiodine Administration in Differentiated Thyroid Cancer. DTC, sTg
76  2018 Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival. CH, CH-PD
77  2018 Radiofrequency ablation for treatment of locally recurrent thyroid cancer presenting as a metastatic lymph node with dense macrocalcification: A case report and literature review. RFA
78  2018 Radioiodine refractory differentiated thyroid cancer. DTC, TSH
79  2018 Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease. PTC
80  2018 Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. BM, DTC, HR, SRE
81  2018 Reclassification as NIFTP: a Retrospective Review in a Single Institution with an Emphasis on Workload. NIFTP, PTC
82  2018 Response of Retinoic Acid in Patients with Radioactive Iodine-Refractory Thyroid Cancer: A Meta-Analysis. DTC, RA, RECIST, Tg, WBS, WHO
83  2018 Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid Cancer. DTC, Tg
84  2018 Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. PTC
85  2018 Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system. ATC, TKI
86  2018 Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer. HR, MLN, PTC, SPECT, Tg
87  2018 Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. MDS, MPN, WDTC
88  2018 Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer. AML, CML, SHMs, WDTC
89  2018 Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine. mETE, PTC, Tg, US
90  2018 Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease. DTC, stTg
91  2018 Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all". ---
92  2018 Skull Metastasis Extending to the Superior Sagittal Sinus: An Unfamiliar Presentation of Papillary Thyroid Carcinoma. FVPTC, PTC
93  2018 Sorafenib-Induced Acute Pancreatitis in a Patient with Differentiated Thyroid Cancer. DTC
94  2018 Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature. PTC
95  2018 Star-Shaped Intense Uptake of I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq. sTg, WBSs
96  2018 Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria. DTC, m-TKIs
97  2018 Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. DTC, RAIR, Tg, WBS
98  2018 Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report. TKIs
99  2018 Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study. AEs, DTC, HR, PFS
100  2018 The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy. DTC, Li, OS, PFS, rhTSH, THW